Skyviews Life Science

Tropic Biosciences UK LTD is a biotechnology company focused on developing high-performing commercial varieties of tropical crops, specifically targeting the coffee and banana industries. Established in 2016 and headquartered in Norwich, United Kingdom, the company employs advanced non-GMO gene editing technologies to enhance crop performance while promoting grower wellbeing and consumer health. Through its innovative approach, Tropic Biosciences aims to improve sustainable agricultural practices and address the challenges faced by tropical crop producers.

BCD Bioscience, Inc. designs and develops an oligosaccharide library and a roadmap that connects precise carbohydrate structures with their functions as prebiotics and immunomodulators to develop pharmaceutical and food ingredients. It offers a platform for creating and commercializing novel prebiotics, synbiotics, and immuno- modularity therapies for human and animal health. BCD Bioscience, Inc. was formerly known as Calyxo Biosystems, Inc. and changed its name to BCD Bioscience, Inc. in November 2019. The company was incorporated in 2019 and is based in Davis, California.

Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing of rationally-defined bacterial consortia in powder form, enabling physicians to access live bacteria drug to treat autoimmune and inflammatory diseases easily. It was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Aleph Farms Limited, based in Ashdod, Israel, specializes in the production of clean meat through innovative cellular agriculture techniques. The company focuses on growing real beef steaks and other meat products directly from the cells of living cows, utilizing proprietary three-dimensional bioprinting technologies. This approach allows Aleph Farms to create lab-cultured meat products, including ground meat and beef burger patties, without the need for animal slaughter. As a leader in the sustainable food ecosystem, Aleph Farms aims to reshape the global meat market, which is valued at over $1 trillion. Co-founded with The Kitchen Hub and the Technion Institute of Technology, Aleph Farms has garnered significant investment to support its mission to provide clean and healthy alternatives to traditional meat products.

Aleph Farms Limited, based in Ashdod, Israel, specializes in the production of clean meat through innovative cellular agriculture techniques. The company focuses on growing real beef steaks and other meat products directly from the cells of living cows, utilizing proprietary three-dimensional bioprinting technologies. This approach allows Aleph Farms to create lab-cultured meat products, including ground meat and beef burger patties, without the need for animal slaughter. As a leader in the sustainable food ecosystem, Aleph Farms aims to reshape the global meat market, which is valued at over $1 trillion. Co-founded with The Kitchen Hub and the Technion Institute of Technology, Aleph Farms has garnered significant investment to support its mission to provide clean and healthy alternatives to traditional meat products.

Cellares Corporation, founded in 2019 and based in South San Francisco, California, focuses on advancing cell therapy manufacturing for cancer treatment. The company aims to address the significant challenges associated with the production of cell therapies, which are often expensive and time-consuming due to their current one-patient-at-a-time manufacturing model. Cellares is developing The Cell Shuttle, an innovative automated and closed end-to-end manufacturing solution designed to enhance scalability and reduce costs. This system allows for the simultaneous production of multiple patient doses, increasing efficiency by tenfold compared to traditional methods. Additionally, The Cell Shuttle is expected to decrease process failure rates by three times and reduce manufacturing costs per patient by up to 70%. By integrating advanced technologies into the production process, Cellares is committed to accelerating access to life-saving therapies for patients in need.

Developer of immunity-boosting proteins designed to improve the lives of people who suffer from food allergies and gluten-related disorders. The company's technology uses artificial intelligence, immunology, computational biology, and protein engineering to make safe proteins that do not trigger an immune response, enabling physicians to prescribe to people products that are safe to consume.

Tropic Biosciences UK LTD is a biotechnology company focused on developing high-performing commercial varieties of tropical crops, specifically targeting the coffee and banana industries. Established in 2016 and headquartered in Norwich, United Kingdom, the company employs advanced non-GMO gene editing technologies to enhance crop performance while promoting grower wellbeing and consumer health. Through its innovative approach, Tropic Biosciences aims to improve sustainable agricultural practices and address the challenges faced by tropical crop producers.

BCD Bioscience, Inc. designs and develops an oligosaccharide library and a roadmap that connects precise carbohydrate structures with their functions as prebiotics and immunomodulators to develop pharmaceutical and food ingredients. It offers a platform for creating and commercializing novel prebiotics, synbiotics, and immuno- modularity therapies for human and animal health. BCD Bioscience, Inc. was formerly known as Calyxo Biosystems, Inc. and changed its name to BCD Bioscience, Inc. in November 2019. The company was incorporated in 2019 and is based in Davis, California.

COMPASS Pathways is a mental health care company focused on developing innovative treatments for mental health conditions. It specializes in the formulation of COMP360, a psilocybin-based therapy currently undergoing Phase IIb clinical trials aimed at treating patients with treatment-resistant depression. The company operates across multiple sites in Europe and North America, conducting large-scale clinical trials to evaluate the efficacy and safety of its psilocybin therapy. Founded in 2016 and incorporated in 2020, COMPASS Pathways is headquartered in Altrincham, Cheshire, United Kingdom. The company's mission is to enhance patient access to evidence-based mental health solutions.